Benzothiazole derivatives as DYRK1 inhibitors

The present invention relates to compounds of Formula (I), which are DYRK1A and/or DYRK1B inhibitors, and their use in the treatment of neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD), metabolic disorders such as Metabolic Syndrome or diabetes mell...

Full description

Saved in:
Bibliographic Details
Main Authors Svendsen, John Sigurd, Porter, Roderick Alan, Stensen, Wenche
Format Patent
LanguageEnglish
Published 23.02.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first